Advanced search
Show most relevant results first | Most recent results are first | Show use by person

Search only Stephen DonnellySearch all speeches

Results 1-1 of 1 for drugs segment:7702252 speaker:Stephen Donnelly

Written Answers — Department of Health: Medicinal Products (14 Jul 2020)

Stephen Donnelly: ...for medicine pricing and reimbursement decisions, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013. On 11 June 2019, the HSE Leadership Team approved access to the drug Nusinersen (Spinraza) for children with Spinal Muscular Atrophy (SMA) Type I, II or III on an exceptional and individualised basis. The HSE decision process in relation to Spinraza...

   Advanced search
Show most relevant results first | Most recent results are first | Show use by person

Search only Stephen DonnellySearch all speeches